Reset filters
  • 26 October 2007

Once-daily nevirapine doesn't improve adherence, may increase risk of treatment break and resistance

Read the article
  • 19 October 2007

Fosamprenavir: US approves once-daily dose with less ritonavir boosting

Read the article
  • 19 October 2007

Atripla takes a key step towards European approval

Read the article
  • 18 October 2007

Financial worries predict poor adherence to anti-HIV therapy in US patients

Read the article
  • 17 October 2007

Up to 40% of ART recipients in Africa have died or discontinued treatment within two years

Read the article
  • 10 October 2007

Kenya: treatment literacy lagging behind ARV rollout

Read the article
  • 26 September 2007

How to deliver good adherence support: lessons from round the world

Read the article
  • 19 September 2007

ICAAC: In NNRTI-based regimens, stepwise discontinuation minimises risk of antiretroviral resistance

Read the article
  • 12 September 2007

Virologically failing NNRTI regimens have higher resistance risk than failing boosted-PIs

Read the article

Receive the latest HIV research and conference news

Complete this form to receive regular email bulletins including the latest HIV research and conference news from aidsmap and/or updates from Terrence Higgins Trust.

Get regular email bulletins

Please let us know how you'd like to be contacted by ticking the options below.